The status of cervical cytology in Swaziland, Southern Africa: A descriptive study

CytoJournal

Volumn 6, Issue , 2009, Pages

  Okonda, Sylvain ^a   Wright, Colleen ^b   Michelow, Pam ^c  

^a Ministry of Health and Social Welfare   (Swaziland)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cervical screening; HPV; low resource communities

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; SWAZILAND; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 77956567218     PISSN: 09745963     EISSN: 17426413     Source Type: Journal    
DOI: 10.4103/1742-6413.54916     Document Type: Article

References (40)

1. Ferlay J, Bray F, Pisani P, Parkin DM: International Agency for Research on Cancer (IARC). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: IARCPress; 2004; Cancer Base No 5, version 2.0.
2. Parkin D, Whelan S, Ferlay J, et al, editors. Cancer Incidence in Five Continents, vol 8. Lyon: IARC Press; 2002, IARC Scientific Publications No. 155.
3. Steward BW, Kleihues P. World Cancer Report. Lyon: IARC Press. 2003.
4. Sepulveda C, Prado R. Effective cervical cytology screening in middle-income countries: The Chilean experience. Cancer Detect Prev 2005;29:405-11.
5. Geography Atlas for Swaziland. Macmillan Swaziland National Publishing Company; 2005
6. Swaziland population census 2007. Central Statistic Office
7. Peers F, Keen P. Swaziland Cancer Registry 1979-83. In: DM Parkin, editor. Cancer Occurrence in Developing Countries. Lyon. IARC. Scientific Publication; 1986.
8. Okonda SL. Population-based cancer registry in Swaziland, 1996-99. In: Parkin DM, Ferlay J, Hamdi-Cherif, et al, editor. Cancer in Africa: Epidemiology and Prevention. IARC. Scientific Publication No 153. IARC Press Lyon; 2003.
9. Okonda SL, Dlamini EM and Fraser MG. Pathology-based cancer database in Swaziland, 1990-95. J Reg Mgmt 2003;20:53-6.
10. -2004 Report on the global AIDS epidemic: 4 th global report. UNAIDS.
11. American Society of Cytopathology. Cervical Cytology Practice Guidelines. Diagn Cytopathol 2000;25:3-21.
12. Koss L, The Papanicolaou test for cervical cancer detection: a triumph and tragedy. JAMA 1989,261: 737-743.
13. Solomon D, Davey D, Kurman R, Moriarty A, O′Connor D, Prey M, et al. American Medical Association. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
14. Sodhani P, Singh V, Das DK, Bhambhani S. Cytohistologal correlation as a measure of quality assurance of a cytology laboratory. Cytopathology 1997;8:103-7.
15. Available from: http://www.iarc.com.fr/canreg4.htm. [last accessed on 2008 June 19].
16. Thistle PJ, Chirenje ZM. Cervical cancer screening in a rural population of Zimbabwe. Centr Afr J Med 1997;43:246-51.
17. van Bogaert LJ, Knapp DC. Opportunistic testing of medically underserved women for cervical cancer in South Africa. Acta Cytol 2001;45:313-6.
18. Motti PG, Dallabetta GA, Daniel RW, Canner JK, Chiphangwi JD, Liomba GN, et al. Cervical abnormalities, human papillomavirus and human immunodeficiency virus infections in women in Malawi. J Infect Dis 1996;173:714-7.
19. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV infected women in Lusaka, Zambia. Gynecol Oncol 2006;103:1017-22.
20. Castellsagu X, Klaustermeier J, Carrilho C, Albero G, Sacarlal J, Quint W, et al. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention. Int J Cancer 2008;122:1901-4.
21. Ng'Andwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC. The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis 2007;16:77.
22. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, et al. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 2007;96:1480-3.
23. Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, et al. Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol 2004;73:481-5.
24. Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, Todd J, et al. The interrelation of HIV, cervical human papillomavirus and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect 2001;77:248-54.
25. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 2003;71:265-73.
26. Marais DJ, Sampson CC, Urban MI, Sitas F, Wiliamson AL. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18 and HPV-11 capsid-antigens in mothers and their children. J Med Virol 2007;79:1370-4.
27. Cervical cancer screening in developing countries: report of a WHO consultation. World Health Organization 2002.
28. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstet 2005;89:504-12.
29. Shastri S, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al. Concurrent evaluation of visual, cytology and HPV testing screening method in the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 2005;83:186-94.
30. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13. (Pubitemid 38758519)
31. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, Rehman R, Cronje H, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86:440-7.
32. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.
33. Howard M, Sellors J, Kaczorowski J. Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia. Obstetric Gynecol 2002;100:980-2.
34. Sellors J. HPV in screening and triage: towards an affordable test. HPV Today 2005;8:4-5.
35. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mah C, et al. Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.
36. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 2001;285:3107-15.
37. Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003;31:41-6.
38. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical cancer. Cancer 1993;71;402-506.
39. Maiman M, Frutcher RG, Clark M, et al. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1993;89:76-80.
40. Clark B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Biol 2002;55:19-24.